To Company Name/Scheme ACN/ARSN 1. Details of substantial holder (1) Name ACN/ARSN (if applicable) - 28/07/2026 The previous notice was given to the company on 28/10/2025 The previous notice was dated 24/10/2025 2. Previous and present voting power *The % substantial is based on...
Change in substantial holding
Filed with ASX ·
6ix hasn’t read this filing yet.
Radiopharm Theranostics Limited on 6ix
Earlier from Radiopharm Theranostics
- Target market determination (TMD)
- Prospectus
- Notice Under Section 708A
- Application for quotation of securities - RAD
- Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up to Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan
Later from Radiopharm Theranostics
- Quarterly Activities/Appendix 4C Cash Flow Report
- Update - Proposed issue of securities - RAD
- Share Purchase Plan - Now Open
- Notice of Extraordinary General Meeting and Proxy Form
- RAD to meet with US FDA to align on RAD 101 Phase 3 Trial
